Invivotek (InVivotek, LLC)

CDMO

United States

https://www.invivotek.com/

Is this your company? Claim this profile

Contract Research Organization

Company Overview

About

Invivotek (InVivotek, LLC) is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Formulation Development, Process Development, Scale-up

Therapeutic Areas

Immunology

Rheumatology

Quick Facts

HQ:United States

Founded:1998

Employees:1,142

Capabilities & Services

Core Capabilities

Peptide Synthesis
Small Molecule API
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Inhalation

Containment Capabilities

OEB 5 (≤1 µg/m³)

Cytotoxic / ADC Handling

Production Scales

Phase III Clinical Trials

Commercial Scale

Clinical

Markets Served

Asia-Pacific

Regulatory Approvals

Drug Approval TNPECJ

FDA · #APR-KW949YY9 · 2022-09-01

Drug Approval W4JDJF

FDA · #APR-6E23USM3 · 2022-05-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

FDA Registration

U.S. Food and Drug Administration

Cert #: CERT-GX9YX1WW

Issued: 2020-03-18

Expires: 2025-08-07

ISO 9001:2015

International Organization for Standardization

Cert #: CERT-6TJXYSZ6

Issued: 2020-05-13

Expires: 2025-12-16

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Invivotek (InVivotek, LLC)

Invivotek (InVivotek, LLC) is headquartered in the United States.
Invivotek (InVivotek, LLC) was founded in 1998.
Invivotek (InVivotek, LLC) has 1,142 employees.
Invivotek (InVivotek, LLC)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

Find CDMOs like Invivotek (InVivotek, LLC)

Directory pages this company appears in, each with the full list of matching manufacturers.

CDMOs in United States CDMOs in North America Small Molecule API CDMOs Formulation Development CDMOs Inhalation CDMOs OEB 5 (≤1 µg/m³) CDMOs Cytotoxic / ADC Handling CDMOs